BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 23179522)

  • 1. MRI-guided core biopsy of the prostate in the supine position--introduction of a simplified technique using large-bore magnet systems.
    Schwab SA; Kuefner MA; Adamietz B; Engelhard K; Keck B; Kunath F; Wach S; Wullich B; Uder M; Engehausen DG
    Eur Radiol; 2013 May; 23(5):1415-9. PubMed ID: 23179522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of magnetic resonance imaging-guided prostate biopsy in the supine position on the detection of significant prostate cancer in an inhomogeneous patient cohort.
    Engelhard K; Kühn R; Osten A; Bogner K; Dworak A; Lübke L; Schneider F
    Scand J Urol; 2016; 50(2):110-5. PubMed ID: 26539999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate biopsy in the supine position in a standard 1.5-T scanner under real time MR-imaging control using a MR-compatible endorectal biopsy device.
    Engelhard K; Hollenbach HP; Kiefer B; Winkel A; Goeb K; Engehausen D
    Eur Radiol; 2006 Jun; 16(6):1237-43. PubMed ID: 16447048
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-bore transrectal MRI-guided prostate biopsies: Are there risk factors for complications?
    Meier-Schroers M; Homsi R; Kukuk G; Wolter K; Decker G; Fischer S; Marx C; Schmeel FC; Block W; Sprinkart AM; Traeber F; Schild HH; Willinek W
    Eur J Radiol; 2016 Dec; 85(12):2169-2173. PubMed ID: 27842662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
    Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
    Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-bore MRI-guided biopsy: can it optimize the need for periodic biopsies in prostate cancer patients undergoing active surveillance? A pilot test-retest reliability study.
    Elfatairy KK; Filson CP; Sanda MG; Osunkoya AO; Geller RL; Nour SG
    Br J Radiol; 2018 Apr; 91(1084):20170603. PubMed ID: 29308912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
    Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
    Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrospective comparison of direct in-bore magnetic resonance imaging (MRI)-guided biopsy and fusion-guided biopsy in patients with MRI lesions which are likely or highly likely to be clinically significant prostate cancer.
    Venderink W; van der Leest M; van Luijtelaar A; van de Ven WJM; Fütterer JJ; Sedelaar JPM; Huisman HJ
    World J Urol; 2017 Dec; 35(12):1849-1855. PubMed ID: 28871396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigen.
    Quentin M; Blondin D; Arsov C; Schimmöller L; Hiester A; Godehardt E; Albers P; Antoch G; Rabenalt R
    J Urol; 2014 Nov; 192(5):1374-9. PubMed ID: 24866597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supine breast MRI and assessment of future clinical applications.
    Siegler P; Ebrahimi M; Holloway CM; Thevathasan G; Plewes DB; Martel A
    Eur J Radiol; 2012 Sep; 81 Suppl 1():S153-5. PubMed ID: 23083571
    [No Abstract]   [Full Text] [Related]  

  • 11. 3-T Multiparametric MRI Followed by In-Bore MR-Guided Biopsy for Detecting Clinically Significant Prostate Cancer After Prior Negative Transrectal Ultrasound-Guided Biopsy.
    Hosseiny M; Shakeri S; Felker ER; Lu D; Sayre J; Ahuja P; Raman SS
    AJR Am J Roentgenol; 2020 Sep; 215(3):660-666. PubMed ID: 32755166
    [No Abstract]   [Full Text] [Related]  

  • 12. 1.5-T magnetic resonance-guided transgluteal biopsies of the prostate in patients with clinically suspected prostate cancer: technique and feasibility.
    Bodelle B; Naguib NN; Schulz B; Eichler K; Müller C; Hansmann ML; Hammerstingl R; Hübner F; Vogl TJ; Zangos S
    Invest Radiol; 2013 Jun; 48(6):458-63. PubMed ID: 23385402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study.
    Hoeks CM; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Roobol MJ; Bul M; Hambrock T; Witjes JA; Fütterer JJ; Hulsbergen-van de Kaa CA; Barentsz JO
    Invest Radiol; 2014 Mar; 49(3):165-72. PubMed ID: 24220253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-Bore MR-Guided Biopsy Systems and Utility of PI-RADS.
    Fütterer JJ; Moche M; Busse H; Yakar D
    Top Magn Reson Imaging; 2016 Jun; 25(3):119-23. PubMed ID: 27187168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transperineal MR-guided stereotactic prostate biopsy utilizing a commercially available anorectal biopsy device.
    Wolter K; Decker G; Willinek WA
    Rofo; 2013 Feb; 185(2):116-20. PubMed ID: 23371867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MR-guided biopsy of the prostate: comparison of diagnostic specimen quality with 18 G and 16 G biopsy needles.
    Durmus T; Goldmann U; Baur AD; Huppertz A; Schwenke C; Hamm B; Franiel T
    Eur J Radiol; 2013 Dec; 82(12):e749-54. PubMed ID: 24034834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Diagnostic Performance of Short Magnetic Resonance Imaging Protocols for Prostate Cancer Detection in Biopsy-naïve Men: The Next Step in Magnetic Resonance Imaging Accessibility.
    van der Leest M; Israël B; Cornel EB; Zámecnik P; Schoots IG; van der Lelij H; Padhani AR; Rovers M; van Oort I; Sedelaar M; Hulsbergen-van de Kaa C; Hannink G; Veltman J; Barentsz J
    Eur Urol; 2019 Nov; 76(5):574-581. PubMed ID: 31167748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-Choline PET/MRI: The Additional Value of PET for MRI-Guided Transrectal Prostate Biopsies.
    Piert M; Montgomery J; Kunju LP; Siddiqui J; Rogers V; Rajendiran T; Johnson TD; Shao X; Davenport MS
    J Nucl Med; 2016 Jul; 57(7):1065-70. PubMed ID: 26985061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MRI-Guided In-Bore Biopsy: Differences Between Prostate Cancer Detection and Localization in Primary and Secondary Biopsy Settings.
    Schimmöller L; Blondin D; Arsov C; Rabenalt R; Albers P; Antoch G; Quentin M
    AJR Am J Roentgenol; 2016 Jan; 206(1):92-9. PubMed ID: 26700339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiparametric-MRI-Guided Biopsy in the Era of Precision Medicine.
    Bergero MA; Martínez PF; Radtke JP; Hadaschik BA
    Arch Esp Urol; 2017 Dec; 70(10):833-844. PubMed ID: 29205162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.